HART response to incorrect statements from Fraser Myers, published by Spiked
Health Advisory & Recovery Team | May 12, 2023
Spiked has published a spiteful article by Fraser Myers that claims HART is “notorious for its anti-vax statements”. This follows a debate between him and Andrew Bridgen MP on GB News in which Bridgen brought along facts and Myers repeated the phrase “anti-vax conspiracy theory” numerous times. In turn, the debate had come about after Myers had published a shoddy attack — short on facts and heavy on invective — on Bridgen a week previously. The Spiked article was brutally dismembered by Will Jones at Daily Sceptic.
Perhaps stung by this, Myers produced the offending article, bringing HART into the picture after we asked for clarification about funding that Spiked had previously received from Pfizer. Nick Dixon, also of Daily Sceptic, has attempted to triangulate the state of play. We have written a longer piece about this episode; numerous others have opined on the matter. David Paton stated that Myers “would have more credibility in this debate if Spiked addressed their inexcusable support for sacking unvaccinated care workers” having supported this policy in July 2021.
Myers’ unpleasant statement about HART sits alongside various incorrect facts. We are happy to put the record straight and — as Myers has stated that this is his final word on the matter — we are pleased that this debate can be put to bed… unless, of course, Myers was just shooting from the hip with that statement and intends to continue the discussion.
- Myers claims it is wrong to call the vaccines experimental. The injections were always experimental, which was why Pfizer’s Chief Scientific Officer described Israel as a “sort of laboratory” for the covid vaccines and why the world eagerly awaited evidence that they might work. The Pfizer phase 3 trial for safety does not officially conclude until 31st December 2023, but they destroyed the control by offering them the vaccine so the proper phase 3 safety studies will never complete. The safety aspect of Pfizer’s pregnancy, immunocompromised and myocarditis/pericarditis studies do not complete until 31st March 2026. The appropriate phase 0 pre-clinical work to measure the amount of spike protein produced in the body and how long it lasts has still not been done, or has not been made public.
- Myers claims it was wrong to call the injections a gene therapy simply because they are not thought to alter a person’s DNA. According to Moderna’s filing in June 2020 “mRNA has been characterised as a Gene Therapy Medicinal Product.” BioNTech agreed in a filing in March 2020 saying, “mRNA therapies have been classified as gene therapy medicinal products.” Do these companies not know what they’re talking about?
- Myers quotes early safety data saying that there were 139 adverse reactions in the vaccine arm and 97 in the placebo arm, claiming that it “isn’t an enormous difference”. These figures are from table 2 of the paper he references but he has not read the whole of table 2. This works out at an extra 12.5 events per 10,000 participants, which is 1 in 800 and exactly what Bridgen claimed. In the UK that would account for 52,000 such injuries after the second dose alone and would be properly defined as “uncommon” not “rare”. It is worth remembering that this terminology is designed for describing the harms from drugs given for treating people who are already sick. Serious harm caused to healthy people at a rate of 1 in 800 is totally unacceptable. Remember these were only the worst adverse events – life changing events, hospitalisations or deaths – which had all occurred during the short period of follow up at the very beginning of the safety trials. There had only been a median of 2 months follow-up at that point. For some participants the ink was metaphorically still wet on their consent forms. Any events that occurred after the cut off were not included in the study. He is right that others have criticised that paper but none of the critics have attempted their own analysis to estimate the scale of harm. It is also worth noting that this is a very high rate of serious adverse events — more frequent than 1 in 1,000 is properly termed ‘uncommon’ rather than ‘rare’ and certainly not ‘very rare’. Assuming a similar adverse reaction rate for later doses, such a rate would amount to over a hundred thousand such serious adverse events in the UK after 151 million jabs.
- Myers then complains that 1 in 800 refers to the number of events, not the number of people affected. The same paper points out that the published trial data is inadequate to make that assessment. FDA data showed twice as many vaccine recipients had multiple adverse events as placebo participants which further suggests a genuine issue here.
- Myers then claims the number needed to vaccinate (“NNV”) calculations from UKHSA were based on 2023 data. That is not correct: they were based on data from July 2022. At the time vaccines were still being pushed on the whole population. The estimates they calculated of thousands to hundreds needing to be vaccinated to prevent a serious hospital admission tally well with the estimates HART carried out for the NNV to prevent a single death from the Delta wave, using UKHSA’s own data.
HART can cite multiple other sources to evidence the claim that the covid injections were harmful and caused deaths, but what do we know? Myers has, after all, declared that HART is “notorious for its anti-vax statements”. But at least we’ve looked into the matter and attempted to shed light on some very iffy claims made by the authorities. If that has saved one person from suffering an unnecessary adverse effect, our consciences are clear — we will sleep well knowing we did what we could.
Others, however, will have to look themselves in the mirror for evermore and know what they have done.
FBI Contractor Created Fake Online IDs to Join Chatrooms Run by Groups Organizing Against Vaccine Mandates
By Brenda Baletti, Ph.D. | The Defender | May 12, 2023
An FBI surveillance contractor infiltrated the chatrooms of two airline industry groups opposed to vaccine mandates to collect intelligence on the groups’ organizing activities, investigative journalist Lee Fang reported.
The contractor, Flashpoint, which in the past infiltrated Islamic terror groups, now focuses on “anti-vaccine” groups and other domestic political organizations, according to Fang.
In a webinar presentation for clients last year, which Fang analyzed on his Substack, Flashpoint analyst Vlad Cuiujuclu demonstrated his company’s methods for identifying and entering encrypted Telegram chat groups.
He explained how the company attempted to join chatrooms of transportation workers resisting the COVID-19 vaccine mandates.
Fang described the presentation:
“‘In this case, we’re searching for a closed channel of U.S. Freedom Flyers,’ said Cuiujuclu. ‘It’s basically a group that opposed vaccination and masks.’
“As he clicked through a database, Cuiujuclu showed a chat group on Telegram sponsored by Airline Professionals For Justice, another group formed by airline industry workers opposed to the mandate. The forum, he added, provided useful insights, including Zoom links for meetings of the grassroots organization.
“‘Private chats,’ said Cuiujuclu, ‘require for you to have an invite link,’ which he noted can often either be found by scrolling through public forums or by ‘engag[ing] the admin of that channel.’”
Flashpoint also offers clients artificial intelligence and internet scraping tools.
According to Fang, the firm is a leader in the “threat intelligence industry,” a growing number of security and surveillance firms that create fake online identities to infiltrate Discord chats, WhatsApp groups, Reddit forums and dark web message boards to gather information for clients, including corporations and the FBI, to monitor potential threats.
Joshua Yoder, president of US Freedom Flyers, said he is aware that Flashpoint infiltrated private chat groups associated with his organization.
Yoder told The Defender :
“Tradecraft and other strategies are often used to gain inside knowledge of conservative organizations with the intent to disrupt, mislead and otherwise thwart effective campaigns.
“Infiltration is a tactic used by the deep state to prevent the truth from being told by attempting to destroy the advancement of the message. The team at US Freedom Flyers has been successful in recognizing these attacks and we have taken decisive actions to protect the organization and our members.”
Aviation industry workers were some of the most vocal and organized against COVID-19 vaccine mandates.
They wrote an open letter to the aviation industry signed by thousands of organizations, physicians and pilots. They also organized research on the risks of vaccines for pilots, spoke publicly about the “culture of fear and intimidation” around the mandates in the industry, and filed multiple lawsuits in Canada, the Netherlands, and the U.S.
US Freedom Flyers brought a lawsuit against Atlas Air, one of the largest air cargo carriers in the aviation industry, in May 2022.
Fang told The Defender the targeting of American citizens resisting the vaccine mandates fits into a long history of surveillance being used to subvert democracy. He said:
“There is a long sordid history of informants and surveillance contractors working to undermine democratic engagement in this country.
“The push against regular citizens opposed to COVID-19 vaccine mandates has come in many forms: censorship, demonization and in this case, surveillance.”
The growing market for spying on domestic dissent
Flashpoint advertises its surveillance success on its website, providing examples of its work undermining environmental activism, G20 protests and protests against the aviation industry.
The webpages describing these activities were taken down after Fang published his investigation, but they can be found on the Wayback Machine internet archive.
For example, Flashpoint described its capacity to monitor activists organizing against pollution and the aviation industry. The website said:
“By monitoring the situation and assessing tactics, techniques, and procedures (TTP’s), Flashpoint was able to assess the impact of upcoming protests, and determine that these groups would likely continue to protest and attempt to impede airport construction and expansion projects through direct action. …
“Based on this information, Flashpoint customers were able to take actions to help control the impact to business operations, and to ensure the safety of their employees and facilities as well as the safety of those protesting.”
Flashpoint was founded by Evan Kohlmann, former NBC News contributor who investigated Islamic terror groups and whom The Intercept described as “the U.S. government’s go-to expert witness in terrorism prosecutions.”
Jack Poulson of Tech Inquiry, a group that researches the surveillance industry, told Fang that “Flashpoint has been selling its chatroom infiltration services to companies and governments for years.”
But, he said, it has shifted its focus from “surveilling Muslims after September 11” and “followed the money into both the Pentagon’s information warfare programs and the business of monitoring domestic protest groups.”
Last year, Flashpoint acquired Echosec Systems, another intelligence contractor, and last month it formalized a partnership with Google Cloud.
These acquisitions come in addition to “a steady stream of contracts to Flashpoint in recent years from the FBI, the Department of Defense, Treasury Department, and Department of Homeland Security, among other agencies,” Fang wrote.
Fang also spoke to Jay Bhattacharya, M.D., Ph.D., professor of medicine at Stanford University, research associate at the National Bureau of Economics Research and one of the authors of the Great Barrington Declaration.
Bhattacharya said:
“This kind of domestic spying violates the implicit protection Americans have in these kinds of settings.
“This isn’t terrorism, this doesn’t have anything to do with national security.
“This is a private set of employees, workers who are trying to maintain their jobs in the face of unscientific demands for COVID vaccinations.”
Brenda Baletti Ph.D. is a reporter for The Defender. She wrote and taught about capitalism and politics for 10 years in the writing program at Duke University. She holds a Ph.D. in human geography from the University of North Carolina at Chapel Hill and a master’s from the University of Texas at Austin.
This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.
Pfizer trial data showed danger for babies but health czars recommended jabs to pregnant women anyway
By Guy Hatchard | TCW Defending Freedom | May 11, 2023
A PREPRINT paper published this month highlights just how many unknowns we are dealing with when it comes to assessing the long-term outcomes of mRNA vaccination. It shows that IgG4 antibodies are present in umbilical cord blood of infants born to vaccinated mothers, meaning a theoretical risk to newborns of an ineffective response to Covid infection.
But was this really unknown to those recommending that mRNA vaccination was safe for pregnant women? Documents released by Pfizer under court order reveal that Pfizer and the US Food and Drug Administration (FDA) were well aware of clinical trial results indicating appalling outcomes for babies of pregnant women.
Watch this 20-minute video where dozens of so-called experts in New Zealand are recorded telling us that the mRNA Covid vaccines are completely safe for pregnant women in direct contradiction of Pfizer trial results available in April 2021. These results indicated an unfolding disaster for babies including miscarriage, premature birth, cardiac arrest, toxic breast milk and spike protein crossing the placenta.
In the video, their comments are juxtaposed with scientists exposing the highly disturbing content of the Pfizer trials of pregnancy outcomes.
Was the NZ government aware of this information? Certainly the contractual arrangements that our government had made with Pfizer would have required Pfizer to fully inform the Ministry of Health of all the results of vaccine trials. But the MoH has completely ignored the information which has become public knowledge. Since the start of this month they are again encouraging pregnant and breastfeeding mothers from 16 and up to get a further booster shot. Why? Especially considering the increased incidence of miscarriages and stillbirths since the NZ vaccine rollout began.
I can’t imagine at this time a more important video to watch than this 20-minute film of our experts lining up to misinform prospective mothers of safety. Were they misled by Pfizer, by the MoH, by politicians, by the FDA, or by all of the above? Or did they just decide to promote a safety rating without any evidence to back up their statements? We may never know, but the lesson of this video is clear: we will not be able to trust the medical czars again.
Andrew Bridgen and Fraser Myers clash in fiery debate on Covid vaccine harms
GBNews | May 8, 2023
Andrew Bridgen, a Member of Parliament in the UK, has been vocal about vaccine harms and the origins of Covid.
Fraser Myers, deputy editor of Spiked online, published an article called “The delusions of Andrew Bridgen – Conspiratorial thinking corrodes reason, democracy and humanism”.
The pair joined Andrew Doyle on GB News in a fiery debate.
One Health: A Plan to ‘Surveil and Control Every Aspect of Life on Earth’?
This is part two of a two-part series on the One Health initiative. Read part one here.
By Michael Nevradakis, Ph.D. | The Defender | May 8, 2023
The World Health Organization (WHO) defines “One Health,” as “an integrated, unifying approach that aims to sustainably balance and optimize the health of people, animals and ecosystems,” as they are “closely linked and interdependent” — a concept that on the surface appears to promote noble goals interlinking human and environmental health.
However, some scientists and medical experts are concerned about One Health’s vague goals. Arguing that the concept has been “hijacked,” they question the intent of those involved with the development and global rollout of the concept — including the WHO, the Centers for Disease Control and Prevention (CDC) and the World Bank.
Experts who spoke with The Defender also raised questions about other aspects of the One Health concept, including a biosecurity agenda, a global surveillance system, vaccine passports and restrictions on human behavior.
While these goals are underpinned by a vaguely defined “Theory of Change,” experts told The Defender that major financial interests are at the heart of the One Health agenda, which appears to be closely linked to climate change and sustainable development initiatives promoted by the same global organizations.
One Health objectives include a ‘global takeover of everything’
In a May 1 article, Dr. Joseph Mercola connected the One Health concept, as promoted by global organizations, to the policies and restrictions pursued in response to COVID-19, describing it as an attempted “global takeover of everything.”
Mercola tied the One Health concept to key entities that have supported gain-of-function research. According to Mercola:
“Interestingly, the term ‘One Health,’ which was formally adopted by the WHO and the G20 health ministers in 2017, was first coined by the executive vice president of the EcoHealth Alliance, the same firm that appears to have had a hand in the creation of SARS-CoV-2.”
During the 2019 lecture “Can One Health Help Prevent the Next Pandemic?” EcoHealth Alliance President Peter Daszak, Ph.D., commissioner in The Lancet’s One Health Commission, said “emerging infectious diseases” are “a growing global threat.”
He also argued that many of these emerging diseases are “zoonotic — spread from animals to humans.”
Francis Boyle, J.D., Ph.D., professor of international law at the University of Illinois and a bioweapons expert who drafted the Biological Weapons Anti-Terrorism Act of 1989, questioned this narrative, telling The Defender :
“All these ‘emerging infectious diseases’ are emerging out of their offensive biological warfare weapons programs conducted in their BSL4 [biosecurity level 4] and BSL3 laboratories.
“If you look at the people on the WHO advisory committee dealing with ‘emerging infectious diseases,’ that’s exactly what they are doing — ‘emerging’ them from their labs.”
One example is that of Marion Koopmans, DVM, Ph.D., director of the WHO Collaborating Centre for emerging infectious diseases at Erasmus Medical Centre in the Netherlands and member of the WHO’s One Health High-Level Expert Panel (OHHLEP).
According to Boyle, “Erasmus is where this offensive Nazi biowarfare gain-of-function death science dirty work first became notorious under Fouchier, [who] started the entire controversy over his gain-of-function work there.”
Boyle was referring to Ron Fouchier, Ph.D., who also is deputy head of Erasmus’ Viroscience Department and who, according to Science, “alarmed the world” in 2011, after he and other researchers “separately modified the deadly avian H5N1 influenza virus so that it spread between ferrets” — an early example of gain-of-function research.
Dr. Meryl Nass, an internist and biological warfare epidemiologist who is a member of the Children’s Health Defense scientific advisory committee, said such objectives are kept deliberately vague. She referred to a CDC document that stated:
“Successful public health interventions require the cooperation of human, animal, and environmental health partners … Other relevant players in a One Health approach could include law enforcement, policymakers, agriculture, communities, and even pet owners.
“By promoting collaboration across all sectors, a One Health approach can achieve the best health outcomes for people, animals, and plants in a shared environment.”
Nass wrote on her blog, “I anticipate that One Health will be used to impose changes in the way humans and animals interact … most likely based on the needs of the WEF [World Economic Forum]/elites and not the needs of the people or the animals that will be affected.”
Reggie Littlejohn, founder and president of Women’s Rights Without Frontiers and co-chair of the Stop Vaccine Passports Task Force, told The Defender, “It’s not clear that One Health is prioritizing human health.”
Highlighting the “vague” language employed by the global organizations promoting One Health, Littlejohn said that one goal may be to “govern farm animal health in addition to human health,” through which “they could do things like forcing vaccines on livestock.”
One Health means ‘surveilling everything’
The experts who spoke with The Defender expressed concerns over the biosecurity agenda that is associated with the stated objectives of One Health.
According to Nass, this reflects how the WHO “has been changing into a biosecurity agency,” adding that “the justification, apparently, for the WHO’s director-general to take over jurisdiction of healthcare during pandemics, but also potentially ecosystems, animals and plants, is through One Health.”
Nass noted that One Health “is mentioned several times in the National Defense [Authorization] Act for Fiscal Year 2023” (NDAA), which includes 18 pages on “pandemic preparedness” and a formal definition of the “One Health approach” on page 952 of the act.
Independent journalist and researcher James Roguski also highlighted the prominent placement of One Health in the NDAA and noted that, by formally defining the concept within the act, it is now part of the Code of Federal Regulations.
However, Roguski said the NDAA goes even further:
“The U.S. has pledged a billion dollars a year to the World Bank Pandemic Fund in support of the global health security agenda. The WHO is one of 14 intermediaries who will receive and redistribute some of that billion dollars.
“Basically, it’s capitalism, it’s corruption, it’s an abomination from a health perspective. Let’s just throw money at pharmaceutical companies, build out the infrastructure in these nations and, if you’re making tons of products locally, you’re going to be able to convince the local government to stick them in people’s arms or shove it down their throat.
“And none of it really has shown to be of any health benefit. It’s damage to people’s health.”
Associated with the promotion of a global biosecurity agenda is the development of a global surveillance infrastructure that would purportedly protect human and animal health and the environment. An Oct. 3, 2022, WHO document states:
“The emergence of the SARS-CoV-2 virus that caused COVID-19 has underlined the need to strengthen the One Health approach, with a greater emphasis on connections to animal health and the environment …
“… It uses the close, interdependent links among these fields to create new surveillance and disease control methods. …
“We now have an unprecedented opportunity to strengthen collaboration and policies across these many areas and reduce the risk of future pandemics and epidemics while also addressing the ongoing burden of endemic and non-communicable diseases
“Surveillance that monitors risks and helps identify patterns across these many areas is needed.”
Remarking on this, Littlejohn said One Health’s proponents talk about “interoperable, integrated surveillance systems.” She told The Defender :
“I believe … these surveillance systems of people, animals, plants, and the environment are going to be coordinated by some kind of a global surveillance system that is interoperable globally and integrated.
“Whoever’s running this show, the WHO, the Chinese Communist Party … the Bill and Melinda Gates Foundation, who are the people who really appear to be running the show at the WHO, are going to be able to tap into and see all of our private information. Not just us, but animals and plants.”
Dr. David Bell, a public health physician and biotech consultant and former director of global health technologies at Intellectual Ventures Global Good Fund, told The Defender that what global organizations intend is “surveilling everything.” He said:
“It means surveilling everything, surveilling the climate for possible threats, surveilling animal population, surveilling wildlife, surveilling the soil to see if there’s new traces of virus or bacteria in river systems, et cetera.
“This allows you to ‘discover’ what we already know is nature, and then turn nature into a potential threat or into a threat. The more surveillance you have and the wider it is, the more inevitable ‘threats’ you’ll find … because you can make an argument that almost any new variant virus is a ‘threat.’
“It will allow them to keep a constant kind of fear which then allows you to introduce authoritarian controls such as central bank digital currencies and digital passports … that allow them to monetize the human population more effectively.”
Nass noted that global actors such as the WHO “talk about sharing of specimens during a pandemic … so they can try to make vaccines too. However, they don’t talk about performing surveillance on human beings. But what they did say, which let the cat out of the bag, is that they would want to get informed consent from countries for sharing of genomic data, rather than from individuals.”
Part of this surveillance infrastructure also would include vaccine passports, which figure prominently in the pandemic treaty and amendments to the International Health Regulations (IHR) currently under negotiation at the WHO.
According to Littlejohn:
“I believe that they laid the infrastructure during the COVID-19 crisis, and we’re having a little bit of a ‘break’ here between pandemics, but that structure, that infrastructure is going to snap shut with the next pandemic if we don’t stop it. That structure has to do with vaccine passports.
“It could be called a ‘smart health card’ or ‘digital health ID,’ or even a mandatory digital driver’s license can serve as the platform for a China-style social credit system. And there’s a new bill in front of the Senate right now … the Improving Digital Identity Act of 2023 … It’s a mandatory national ID that’s going to be interoperable, coordinated, integrated and can serve as the same platform as China’s social credit system … to surveil us.”
Restrictions on human behavior could lower humans to the level of animals
The WHO’s Oct. 3, 2022, document also claimed that “Some 60% of emerging infectious diseases that are reported globally come from animals, both wild and domestic,” adding that “human activities and stressed ecosystems have created new opportunities for diseases to emerge and spread.”
Such stressors “include animal trade, agriculture, livestock farming, urbanization, extractive industries, climate change, habitat fragmentation and encroachment into wild areas,” according to the WHO.
“To the extent that carbon emissions due to transportation within cities would contribute to climate change, then the ‘15-minute city’ would be a way of addressing that,” Littlejohn said. “The danger is that they will enforce it by having surveillance cameras everywhere to make sure you don’t go outside of your district without permission.”
In a March 30 article, “Your Daughter for a Rat,” Bell cited a One Health editorial published in The Lancet stating that “all life is equal, and of equal concern.” In response, Bell suggested that One Health aims to lower humans to the level of animals.
The same Lancet article described One Health as “a call for ecological, not merely health, equity” and called for a “subtle but quite revolutionary shift of perspective” away from “anthropocentrism”: “All life is equal, and of equal concern.”
“It looks like this is going to be the justification for moving people down to the value of animals,” Nass said in response; a sentiment shared by Boyle, who said, “One Health relates the healthcare of human beings to the healthcare of animals and thus reduces healthcare for human beings to the level of healthcare for animals.”
According to Bell, “suggesting that we have a duty as a species on this planet to look after every species equally and treat them more equally [is] becoming sort of a religion or dogma. It defies what any rational society in the history of humanity” has practiced and is “a very unusual approach and potentially very scary.”
One Health: Follow the money
The WHO has attempted to give theoretical credence to the One Health concept by developing a so-called “Theory of Change” (ToC).
Although the WHO says the ToC is designed to provide “a conceptual framework” for “organisations, agencies and initiatives working towards similar One Health goals” and a “common narrative of coherence,” the theory itself does not appear to have a clear definition.
“They want to be able to do whatever they want,” Littlejohn said. “If you define it, then you can hold them to the definition … one of the tactics is just to be really obscure and incomprehensible.”
“This is a term that is used in these circles,” Bell added. “It’s stating the obvious, that if you do a certain act, you’ll have a certain outcome. It’s a fancy way of saying that.”
Bell also referred to the “fallacy that is being pushed that humans are having increasing contact with wildlife,” supposedly leading to “this threat of viruses jumping from wildlife to humans.”
Calling it a “ludicrous claim,” Bell said that “when humans move into wildlife habitats, the wildlife don’t start living with humans. They die out.”
Noting that “it used to be very common” for people to live with farm animals, Bell added that the claim that pandemics are becoming more common due to increased contact with animals is itself “not true,” but is “used to instill fear and to try to get people to buy into this One Health, constant health emergency agenda.”
Nass said One Health proponents “don’t actually have any evidence” to support their claims, offering the example of antimicrobial resistance in bacteria found in meat consumed by humans, as a result of antibiotics administered to livestock. “That’s been the hook that One Health has been hung on,” Nass said.
However, Nass said this problem “could be solved in a heartbeat if the U.S. Food and Drug Administration or the U.S. Department of Agriculture just told farmers they can’t put antibiotics into animal feed anymore, they can only use them when an animal gets sick.”
In his recent article, Mercola suggested following the money. “Private interests wield immense power over the WHO, and a majority of the funding is ‘specified,’ meaning it’s earmarked for particular programs. The WHO cannot allocate those funds wherever they’re needed most.”
As a result, this “massively influences what the WHO does and how it does it. So, the WHO is an organization that does whatever its funders tell it to do,” naming organizations such as the Gates Foundation as prime funders of the WHO.
Bell said that supporters of One Health include “those who have been pushing the COVID agenda … and enriching themselves from it,” including “private foundations who are on the bandwagon” and “corporations who stand to gain from controlling the food chain and controlling agriculture and pharmaceuticals, et cetera.”
“It’s corporate authoritarians that have benefited themselves from public health through COVID and the certainly inappropriate COVID response,” Bell added. “And it’s the same and it’s not disconnected with the climate emergency agenda.”
One prominent financial actor closely involved with the development of the One Health agenda is the World Bank, as WHO documents indicate.
At a November 2022 OHHLEP meeting, Franck Berthe, the World Bank’s senior livestock specialist, introduced the World Bank’s Financial Intermediary Fund, which would “allow countries to borrow funds to strengthen their health system and promote the OH [One Health] approach.”
According to Nass, “the WHO and the World Bank have helped form this financing operation for the biosecurity agenda,” while Boyle told The Defender, “There is nothing humanitarian about these backers and the WHO promoting the One Health agenda.”
Both Nass and Bell said the One Health agenda is closely tied to the UN’s Sustainable Development Goals and Agenda 2030. Bell said that the One Health agenda attempts to deal with a supposed “existential threat to human health” that “must be dealt with in a centralized way, rather than giving people a choice.”
One Health closely tied to WHO pandemic treaty, IHR amendments
Experts who spoke with The Defender also emphasized the connections between the One Health concept and the pandemic treaty and IHR amendments under negotiation.
Mercola wrote that through the One Health agenda, which recognizes “a very broad range of aspects of life and the environment [that] can impact health and therefore fall under the ‘potential’ to cause harm,” the WHO “will be able to declare climate change as a health emergency and subsequently require climate lockdowns.”
Roguski, who has extensively researched the pandemic treaty and IHR amendments, said that in amendments the EU recently proposed for the pandemic treaty, the term “One Health” appears 29 times, including calling upon countries to develop and regularly update pandemic prevention plans via the One Health approach.
Referring to the need to prevent potential “pandemic situations,” the proposals also call for strengthening global public health surveillance “using a One Health approach,” which will also “address the drivers of the emergence and re-emergence of disease at the human-animal-environment interface, including but not limited to climate change, land use change, wildlife trade, desertification and antimicrobial resistance.”
The proposals also suggest the One Health approach could be used “to produce science-based evidence, and support, facilitate and/or oversee the correct, evidence-based and risk-informed implementation of infection prevention and control,” and go as far as to suggest targets on “antimicrobial consumption/use.”
Roguski told The Defender that the latest draft of the pandemic treaty refers to One Health 13 times. Such language would “be used to take over complete control of our lives,” Roguski added.
For example, one proposal states, “Each Party shall, in accordance with national law, adopt policies and strategies, supported by implementation plans, across the public and private sectors and relevant agencies, consistent with relevant tools, including, but not limited to, the International Health Regulations, and strengthen and reinforce public health functions for: (c) surveillance (including using a One Health approach).”
Other proposals include:
“The Parties commit to strengthen multi-sectoral, coordinated, interoperable and integrated One Health surveillance systems … to identify and assess the risks and emergence of pathogens and variants with pandemic potential, in order to minimize spill-over events, mutations and the risks associated with zoonotic neglected tropical and vector-borne diseases, with a view to preventing small-scale outbreaks in wildlife or domesticated animals from becoming a pandemic.
“Each Party shall … develop and implement a national One Health action plan on antimicrobial resistance that strengthens antimicrobial stewardship in the human and animal sectors, optimizes antimicrobial consumption, increases investment in, and promotes equitable and affordable access to, new medicines, diagnostic tools, vaccines and other interventions, strengthens infection prevention and control in health care settings and sanitation and biosecurity in livestock farms, and provides technical support to developing countries.”
Roguski said the phrase “One Health” doesn’t directly appear in documents related to the proposed IHR amendments, but he added the WHO “is going to try to get them both to prevail,” referring to both the treaty and IHR amendments.
Littlejohn said, the One Health approach and the proposed language in the treaty “gives them the right to surveil and potentially control every aspect of life on earth.”
Noting that the proposed treaty also calls for a “commitment to counteract ‘misinformation,’ ‘disinformation,’ and ‘false news,’” Littlejohn added, “they’re going to surveil our social media … and if any of us steps out of line by contradicting what the WHO says, then we could be censored.”
“That’s what I think is in mind with this commitment to ‘coordinated, interoperable and integrated’ One Health surveillance systems,” Littlejohn added. “I think that’s how it could end up being deployed. Ultimately, globalist entities, such as the World Economic Forum and the UN are using the WHO as their way of establishing global control.”
“The reason that health is such a good pretext is that people can become terrified,” Littlejohn added. “To the extent that their minds are paralyzed if they think they could die or get really sick, they’re willing to give up freedoms that they would not be willing to give up in other contexts.”
Roguski told The Defender :
“They made a lot of bad decisions. They gave a lot of bad advice [and] they caused a lot of harm to a lot of people. You can’t just give those people more power, authority and control without looking at what they did and going, ‘no, you should not be in charge of any of this.’”
In turn, Mercola wrote that “The globalist takeover hinges on the successful creation of a feedback loop of surveillance for virus variants, declaration of potential risk followed by lockdowns and restrictions, followed by mass vaccinating populations to ‘end’ the pandemic restrictions, followed by more surveillance and so on.”
And according to Bell, One Health “is part of a much bigger picture of finding ways to pull apart the intrinsic ideas that most societies have been built on.”
“I think that this is part of a move to undo these sorts of ideas and to replace them with a sort of religion of fear of our surroundings and denigration of other humans that can then be used by very greedy people to increase their wealth and power,” Bell said. “It’s taken over public health to a large extent.”
Michael Nevradakis, Ph.D., based in Athens, Greece, is a senior reporter for The Defender and part of the rotation of hosts for CHD.TV’s “Good Morning CHD.”
This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.
Biden regime & WHO finally realise nobody cares anymore, fold up last vestiges of the Covid circus
Polish health minister denounces Pfizer vax profiteering, amazingly asks if it is “only about money”
eugyppius: a plague chronicle | May 7, 2023
The Biden Administration have announced that their insane vaccine requirements for government employees and international travellers will finally end on 11 May, when the American pandemic state of emergency expires. The WHO have likewise declared that Covid-19 “no longer constitutes a public health emergency of international concern.” Three years and two months after it all started, the last remaining participants in the Covid circus are finally folding up their tables and going home.
It’s worth asking why now, because by any objective measure, there has been no virus activity worthy of the words ‘pandemic’ or ‘emergency’ for a very long time. The answer seems to be the failure of Corona to return in the winter, as long-absent influenza succeeded in suppressing Corona infections (in accordance with my prediction), and the increasing disinterest of the public in obtaining official test results has put all virus statistics in the toilet. They’re ending it now, in other words, not because anything on the ground has changed, but because they no longer have any hope of the scary headlines necessary to keep the machine up and running.
As in the beginning, so in the end: The pandemicists will give you always and forever the maximum virus suppression and the maximum vaccination that is politically possible. Not what is prudent, or what has any hope of achieving anything, or what has evidence in its favour, but simply the maximum that they can give you, for as long as they can give it to you. That is a reason in itself, never to let the pandemicists anywhere near the levers of power ever again.
The pandemic may be over, but there is no stopping the vaccines. Thanks to the incredibly stupid contracts that the EU concluded with Pfizer/BioNTech, we are drowning in them, and some of our less prosperous neighbours to the east have had enough:
With the Covid vaccination campaigns concluded, the European Union is sitting on an enormous vaccine surplus – and hundreds of millions more doses are expected to arrive this year and next… Because they are not needed, EU member states have been trying for months to retroactively adjust the contracts, without much success.
One country has now lost patience in the face of the tough negotiations, and is venting its anger. The Polish Health Minister Adam Niedzielski on Tuesday sent a letter to the “shareholders of Pfizer” [which] says that the delivery of hundreds of millions of doses planned by Pfizer despite a “stable epidemic situation” is “completely pointless.”
The excess doses can no longer even be given away; there is no government “interested” in Covid vaccines, said the minister …
Niedzielski also breaks prior agreements on the confidentiality of talks between governments, pharmaceutical companies and the mediating EU Commission … [and] reveals what Pfizer is offering the states: They’ll reduce the total quantity of the outstanding orders, in exchange for half the price of each dose that is not produced: “That’s a charge for literally non-existent doses that were never produced and will never be produced and that don’t cost Pfizer a penny.”
No wonder there has been such urgency to keep these negotiations secret.
Niedzielski writes that he is “extremely” sorry, but he is forced to conclude that the company is not prepared to show “a satisfactory level of flexibility and make any realistic proposals.” … The health minister called on Pfizer to “live up to its responsibility towards EU citizens and member states and work in good faith towards a solution that is fair for everyone.” Poland wants to continue to believe that the pharmaceutical industry is not only about money.
Hahhhahahahahahhhahahhhahahahahhahhahahhahhaha.
Video source
Unrepentant Corona arch-villain Christian Drosten re-emerges to give the vaccines credit for ending the pandemic
Insists that lockdowns and school closures remain policy options in the future

Virus-understander-in-chief Christian Drosten posing as a scrappy compassionate avatar of The Science, rather than the conniving and perpetually wrong loser that he is.
eugyppius: a plague chronicle | May 6, 2023
That eternal turd who will not flush, Christian Drosten, has resurfaced with an odious media interview, demanding that the vaccines receive credit for ending the pandemic and that oppressive non-pharmaceutical interventions like lockdowns and school closures remain on the table for future pandemics.
From Tagesspiegel :
The measures taken by the federal and state governments in the Corona pandemic proved highly controversial and triggered fierce debates. The Berlin Charité virologist Christian Drosten, among the advocates of harsh restrictions, has now warned against drawing the wrong conclusions. The “fundamental, ideological exclusion of lockdowns and school closures” is foolhardy, Drosten told the newspapers of the Funke Mediengruppe.
“Not all pathogens have the same characteristics. A virus could surface that is especially dangerous for children, for example, or that triggers insidious sequelae despite a harmless initial infection.”
“The school closures in 2020 and 2021 were a mistake, but please don’t take away our power to close schools again in the future! The next virus might really be dangerous to children! We don’t always cry wolf, except when we do!”
Infections such like mumps and measles have caused brain inflammation, diabetes or infertility, the director of the Institute of Virology added. “If such a virus developed into a highly transmissible pandemic pathogen, politicians would inevitably have to take measures. You can’t categorically rule out things like lockdowns and school closures, that’s neither realistic nor responsible.”
Yes, you can categorically rule out lockdowns and school closures. We literally never did any of this before at this scale or for this duration in response to any virus, nor were lockdowns or other invasive measures ever even contemplated until the Chinese gave you guys a bunch of evil ideas three years ago. What’s more, all of your interventions were utter, abject failures; they did nothing.
Drosten also criticised the public debate on Covid vaccinations, which “is often still destructive.” The fact that further Covid vaccinations for children and many adults are now no longer recommended “does not prove that vaccines have always been unnecessary,” the Charité professor emphasised.
“Rather, with the help of vaccinations, we have mitigated the impact of infections and developed a high level of immunity in the population. This is the only reason that the vaccine recommendations could now be changed.”
Had we vaccinated not a single soul, we’d have identical levels of immunity in the population right now from Omicron. We also wouldn’t have all those awkward vaccine injury headlines.
In case you’re not yet angry enough, though, it gets worse:
The director of the Institute for International Health at Charité, Beate Kampmann, warned against vaccine scepticism. “Vaccination is not only about the well-being of the individual, but also about the health of society as a whole, that is public health, and that also means solidarity,” she told the newspapers.
“Sometimes people forget that they contribute to the protection of everyone with their personal decision. That was true for Corona, but it’s also true for measles, for example.”
Why are these assholes always lying, I want to know. The vaccines were not intended to stop transmission, the trials weren’t designed to show whether they would stop transmission, and we’ve known beyond all doubt since the summer of 2021 that they don’t stop transmission. Nobody who was vaccinated against Corona contributed to anybody else’s health at all, this is all just a straight-up untruth.
The pandemicists aren’t going away. They have amassed a great toolkit of new powers, and they will be slinking around for decades waiting for the next opportunity to try them out all over again. Now that the virus hysteria has boiled off and some minimal standards of rationality have returned to the discussion, it should be a priority to discredit every last one of these virus pests, Corona astrologers, modellers, and panic mongerers, now and for all time. Otherwise we’re at great risk for getting the same thing all over again.
FDA Approves First RSV Vaccine, But Some Experts Say Weak Safety, Efficacy Data Suggest Benefits Don’t Outweigh Risks
By Michael Nevradakis, Ph.D. | The Defender | May 4, 2023
Describing it as a “long-sought scientific achievement,” the U.S. Food and Drug Administration (FDA) on Wednesday approved Arexvy, the first vaccine for respiratory syncytial virus (RSV).
GlaxoSmithKline Biologicals (GSK) developed Arexvy under the FDA’s Priority Review designation. The FDA approved it for people ages 60 and older.
According to CNBC, the U.S. “suffered an unusually severe RSV season” this past winter. The New York Times reported on a “tripledemic” involving RSV, flu and COVID-19, “that swamped children’s hospitals and some I.C.U. wards.”
One U.S. county — Orange County, California — declared a local health emergency and issued a proclamation of local emergency in November 2022, citing rising RSV cases among children in the region.
GSK described results from clinical trials for Arexvy as “positive,” and the company said the U.S. launch of the vaccine is planned before the 2023-24 RSV season.
Other RSV vaccines, including one produced by Pfizer, are in the pipeline and expectations are that the FDA will approve them.
During clinical trials for both the GSK and Pfizer vaccines, several participants were diagnosed with rare conditions such as Guillain-Barré syndrome (GBS) and acute disseminated encephalomyelitis (ADEM). One of the individuals who developed ADEM later died, according to the FDA.
Aside from concerns over potential serious adverse events related to RSV vaccines, some experts have questioned the need for such a vaccine in the first place.
According to the journal Science, “RSV is a common respiratory infection” with symptoms “similar to a cold,” adding that “The majority of individuals recover within a few days from an uncomplicated RSV infection, although occasionally the virus can cause lower respiratory infections requiring medical attention.”
Dr. Peter McCullough, a cardiologist, told The Defender:
“Respiratory syncytial virus is a negligible threat to even the most frail elderly adults. The effort of widespread vaccination is simply not worth it. Even rare side effects will outweigh any theoretical benefit.”
And in a November 2022 episode of “RFK Jr. The Defender” podcast, several medical and public health experts expressed concerns about RSV vaccines.
“We have to stop these shots,” said Dr. Meryl Nass, an internist and biological warfare epidemiologist. “It’s just extraordinary that we’re still vaccinating people … we have a lot of work to do.”
Robert F. Kennedy Jr., then-chairman and chief litigation counsel for Children’s Health Defense (now chairman on leave), described RSV as “a vehicle for re-implementing the COVID-19 playbook all over the country and responding with vaccines.”
And according to the National Vaccine Information Center (NVIC), “Cost analysis data presented to the ACIP [Advisory Committee on Immunization Practices] did not show the RSV vaccines to be cost-effective at reducing the burden of costs associated with RSV illness.”
Nevertheless, more RSV vaccines are expected to receive FDA approval this year — including a Pfizer RSV vaccine for pregnant women that led to a high incidence of adverse events for both the women and their infants during clinical trials, as well as several deaths and stillbirths.
Arexvy approval ushers in new ‘highly competitive and lucrative vaccine market’
The RSV vaccine market is estimated to be worth up to $10 billion by 2030.
According to Endpoints News, the FDA’s approval of Arexvy ends “half a century of failed efforts against the elusive, shape-shifting virus” and “officially start[s] what analysts expect will be a highly competitive and lucrative new vaccine market.”
In getting Arexvy approved, “GSK beat a crowded field of competitors to cross the finish line first.”
Arexvy “showed strong efficacy in stopping lower-respiratory tract infections as well as more severe disease” and will be administered as a single dose, according to Endpoints News.
STAT reported that a “vaccine that was developed by Pfizer and aimed at the same demographic [adults 60 and over] is expected to be approved by the end of the month,” while other RSV vaccines and therapeutics, including some intended for children and pregnant women, are in the pipeline and also are close to receiving FDA approval.
The FDA’s approval of Arexvy came after an FDA advisory panel reviewed data from GSK’s and Pfizer’s clinical trials on March 1. The panel unanimously agreed that GSK’s vaccine is effective and, in a 10-2 vote, deemed it “safe,” according to The Washington Post.
The same panel also approved Pfizer’s candidate vaccine, Abrysvo, but with a 7-4 vote.
On June 21 or 22, ACIP, which advises the Centers for Disease Control and Prevention (CDC), will convene to “make recommendations on the appropriate use of the vaccine in the U.S.,” according to GSK’s announcement. The ACIP must recommend the vaccines before they are marketed.
According to STAT, there is a likelihood that ACIP may not approve Arexvy for its intended age group, stating:
“Though Arexvy’s approval is for adults 60 and older, it remains to be seen if the CDC will recommend it for that entire group.
“At an advisory committee meeting in February, members of a work group studying the adult vaccines that will soon come before ACIP indicated that at present, they don’t believe the vaccine would be cost-effective in people aged 60 to 64 and they would not recommend to the wider committee that it include people 60 to 64 in its recommendation for the use of the vaccine. (The group held the same position for the Pfizer RSV vaccine.)”
In April, the European Medicines Agency (EMA) issued its own recommendation for Arexvy, for adults 60 and over, according to the Times. However, a final EMA regulatory decision is anticipated later this year. GSK is also awaiting licensure for Arexvy in Australia, China, Japan and other countries, STAT reported.
In an earnings presentation April 26, GSK said it has “millions of doses” of Arexvy “ready to be shipped.”
“GSK’s RSV vaccine works by using a small piece of the virus: a protein that sticks out on its surface called the fusion, or F, protein, which helps the virus glom onto and infect cells in the body’s upper airways. The protein pieces in the vaccine are made in a lab, using cells specially programmed to manufacture them.”
CNN noted that the vaccine “builds on a pivotal discovery made a decade ago” by National Institutes of Health researchers, “including some of the same scientists who helped make the COVID-19 vaccines.” Specifically, the researchers figured out how to freeze the otherwise “wiggly” F protein, “in the shape it takes before it fuses onto a cell.”
STAT, quoting Phil Dormitzer, GSK senior vice president and global head of vaccines research and development, reported that although Arexvy “contains only one of the two RSV subtypes, RSV A,” studies showed that it is “virtually equally protective against both RSV A and RSV B” as the F protein on both subtypes is similar.
Dormitzer acknowledged natural immunity, telling STAT, “because older adults have all had RSV probably multiple times by the time they get [the vaccine], they’re primed against both A and B. So you’re able to get very solid boosting against both subtypes with a single adjuvanted F antigen.”
According to GSK, the Arexvy vaccine does not use mRNA technology, but “contains a recombinant subunit prefusion RSV F glycoprotein antigen (RSVPreF3) combined with GSK’s proprietary AS01E adjuvant.”
GSK, FDA claim Arexvy clinical trial data show vaccine is ‘safe and effective’ but annual shot may be needed
The FDA announcement stated:
“The safety and effectiveness of Arexvy is based on the FDA’s analysis of data from an ongoing, randomized, placebo-controlled clinical study conducted in the U.S. and internationally in individuals 60 years of age and older.”
According to the FDA, “approximately 12,500 participants … received Arexvy and 12,500 participants … received a placebo. Among the participants who have received Arexvy and the participants who have received a placebo, the vaccine significantly reduced the risk of developing RSV-associated LRTD [lower respiratory tract disease] by 82.6% and reduced the risk of developing severe RSV-associated LRTD by 94.1%.”
LRTD was “defined as two or more symptoms including shortness of breath, wheezing, cough, increased mucus production, crackles, low oxygen saturation, or need for oxygen supplementation,” according to CNBC, while according to CNN, “People were considered to have severe disease if they needed supplemental oxygen or needed mechanical help to breathe, like a ventilator.”
According to the FDA, half of the 25,000 participants received Arexvy, while the other half received a placebo.
The results of GSK’s clinical trials for Arexvy were published in the New England Journal of Medicine on Feb. 16.
FDA and GSK officials provided glowing reviews of the new vaccine. Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research, said in a statement:
“Older adults, in particular those with underlying health conditions, such as heart or lung disease or weakened immune systems, are at high risk for severe disease caused by RSV.
“Today’s approval of the first RSV vaccine is an important public health achievement to prevent a disease which can be life-threatening and reflects the FDA’s continued commitment to facilitating the development of safe and effective vaccines for use in the United States.”
Tony Wood, GSK’s chief scientific officer, described Arexvy’s approval as “a turning point in our effort to reduce the significant burden of RSV,” adding that “Our focus now is to ensure eligible older adults in the U.S. can access the vaccine as quickly as possible and to progress regulatory review in other countries.”
In turn, Dormitzer said, “There’s just the broad excitement of finally, after all these years, having good options emerging for RSV,” describing this as a “triumph of the basic science.”
While GSK is first out of the gate in the RSV vaccine race with Arexvy, Pfizer’s candidate vaccine has also completed clinical trials, which found it to be “nearly 67 percent effective in preventing R.S.V. – related illness,” according to the Times.
The FDA and GSK announcements did not mention the vaccines’ waning effectiveness. An analysis by the NVIC found that the effectiveness of the GSK vaccine peaked after two months and offered no protection after one year. This may result in recommendations for adults to receive annual doses of the vaccine.
Trial participant died from a rare inflammatory condition, others developed GBS
Despite positive comments from FDA and GSK officials, clinical trial data for Arexvy revealed instances of GBS and other rare conditions.
In its announcement Wednesday, GSK claimed:
“The vaccine was generally well tolerated with an acceptable safety profile. The most frequently observed solicited adverse events were injection site pain, fatigue, myalgia, headache, and arthralgia. These were generally mild to moderate and transient.”
The announcement did not mention GBS.
According to the FDA announcement Wednesday:
“The most commonly reported side effects by individuals who received Arexvy were injection site pain, fatigue, muscle pain, headache and joint stiffness/pain.
“Among all clinical trial participants, atrial fibrillation within 30 days of vaccination was reported in 10 participants who received Arexvy and 4 participants who received placebo.”
However, the FDA noted that in two other Arexvy studies involving approximately 2,500 participants 60 and over, “two participants developed acute disseminated encephalomyelitis (ADEM), a rare type of inflammation that affects the brain and spinal cord, seven and 22 days, respectively, after receiving Arexvy and the influenza vaccine.”
“One of the participants who developed ADEM died,” according to the FDA.
In another Arexvy study conducted by GSK, “one participant developed Guillain-Barré syndrome (a rare disorder in which the body’s immune system damages nerve cells, causing muscle weakness and sometimes paralysis) nine days after receiving Arexvy,” the FDA stated.
According to an FDA briefing document cited by CNBC:
“A 78-year-old woman in Japan was diagnosed with Guillain-Barré syndrome nine days after receiving GSK’s vaccine … She was hospitalized for six months before being released.”
CNBC reported that GSK claimed in February “There is insufficient evidence to confirm the woman got Guillain-Barre as a result of GSK’s shot.” However, the FDA “considers the case to be related to GSK’s vaccine.”
According to the FDA’s announcement:
“The FDA is requiring the company to conduct a postmarketing study to assess the signals of serious risks for Guillain-Barré syndrome and ADEM. In addition, although not an FDA requirement, the company has committed to assess atrial fibrillation in the postmarketing study.”
According to the Times, “Once the shots become available to the public, the agency said it would require GSK to monitor the incidence of Guillain-Barré and another rare condition that was possibly related to the shot.”
The FDA similarly flagged GSK “as a potential safety issue with Pfizer’s RSV vaccine for older adults,” CNBC reported after two clinical trial participants developed GBS. According to the Post, both participants — one man and one woman — were 66 years old.
CNBC in February reported that Pfizer “will conduct a safety study to further address Guillain-Barré syndrome if the FDA approves its vaccine.”
GSK’s chief commercial officer, Luke Miels, said the vaccine would cost upwards of $120 a dose, according to the Post, which also reported that private insurers may cover “many costs” associated with the vaccine, while Medicare patients with Part D coverage “won’t pay anything out of pocket” for the vaccine.
“Shares of GSK rose nearly 2% Wednesday following the approval,” CNBC reported.
GSK is also pressing forward with “A clinical trial that aims to expand the population who may benefit from RSV vaccination into adults aged 50-59, including participants with underlying comorbidities,” according to the company’s Wednesday announcement, with results “expected in 2023.”
Is there a need for an RSV vaccine?
According to the FDA:
“RSV is a highly contagious virus that causes infections of the lungs and breathing passages in individuals of all age groups. RSV circulation is seasonal, typically starting during the fall and peaking in the winter.
“In older adults, RSV is a common cause of lower respiratory tract disease (LRTD), which affects the lungs and can cause life-threatening pneumonia and bronchiolitis (swelling of the small airway passages in the lungs).”
The FDA cited CDC figures claiming each year in the U.S., RSV leads to approximately 60,000-120,000 hospitalizations and 6,000-10,000 deaths among adults 65 years of age and older.”
STAT reported that “RSV season has been unpredictable in the wake of the COVID-19 pandemic, though some experts believe RSV activity is moving back toward the seasonality seen in the pre-COVID days,” noting that “there was little transmission in 2020, when people were wearing masks and social distancing.”
But RSV “returned abnormally early in 2021,” STAT reported, but without an explanation for why this occurred, despite widespread masking and social distancing that year, too.
In the U.S., pediatric deaths from RSV are not common but the infection is the No. 1 cause of hospitalizations for children under the age of 1, STAT reported. Globally, however, it is the second leading cause of death in children under 1, after malaria.
According to STAT, “All but the youngest of children have had RSV multiple times, but few of us would know with any certainty that this bad cold was caused by that bad virus.”
Nevertheless, Pfizer is proceeding with the development of an RSV for infants as young as 6 months — “the age group at highest risk of being hospitalized with RSV,” STAT reported, noting that the vaccine for this age group is expected to gain FDA approval later this year and will be administered to pregnant women “to generate antibodies that protect both the pregnant person and their newborn.”
Data reported by Pfizer to the CDC indicated that 14% of pregnant women who participated in Pfizer’s trial sustained an adverse event, with 4.2% sustaining a “serious” adverse event, 1.7% experiencing a “severe” adverse event and 0.5% suffering a “life-threatening” adverse event.
Similarly, the same data showed that 37.1% of infants whose mothers received the experimental Pfizer vaccine experienced adverse events within one month of birth — with 15.5% classified as “serious,” 4.5% as “severe” and 1% as “life-threatening,” while efficacy waned within months of vaccination.
According to the NVIC, “The RSV clinical trial data also included the death of one pregnant woman, 18 still births (10 in vaccinated pregnant women and 8 in unvaccinated pregnant women), and 17 infant deaths (five from the vaccinated pregnancy group and 12 in unvaccinated pregnancy group).”
In its report to the CDC, Pfizer claimed the deaths were unrelated to the vaccine.
The FDA’s Vaccines and Related Biological Products Advisory Committee will meet virtually on May 18 to discuss approval of this vaccine. The meeting is open to the public, and a public comment period is open until May 17. A final FDA decision is expected in August.
According to the Times, “Moderna is also developing an RSV vaccine for adults 60 and over, with authorization expected in the first half of this year. The Times referenced clinical trial data released by Moderna claiming 82% efficacy, with “no safety concerns identified.”
Bavarian Nordic, known for its development of a vaccine in response to last year’s monkeypox outbreak, is also developing an RSV vaccine for adults 60 and over,” expecting to release Phase 3 clinical trial data by midyear, according to the Post and CNN.
AstraZeneca and Sanofi also are seeking FDA approval, but for nirsevimab, a monoclonal antibody treatment for RSV that would be administered to infants and toddlers up to age 2, according to the Times, which referenced clinical trial results claiming a reduction of illness of up to 75%.
According to the Post, nirsevimab “is already approved in Europe, the United Kingdom and Canada.”
However, the NVIC reported that the effectiveness of nirsevimab “is not known beyond 150 days” and it is unclear if the drug prevents ICU stays or deaths. It is being reviewed by ACIP, which according to the NVIC, is “a federal advisory committee charged with making vaccine use recommendations.”
“It is unclear why the ACIP … has chosen to go beyond its charge of making vaccine use recommendations,” NVIC states.
Safety concerns related to RSV vaccines nevertheless linger. According to CNN, an RSV vaccine developed in the 1960s for children initially delivered promising results during trials in children and animals.
However, once administered to children in the general population, “many of the children who were vaccinated required hospitalization and got more severe RSV disease than what would have normally occurred” — and two of the initial trial participants died.
Michael Nevradakis, Ph.D., based in Athens, Greece, is a senior reporter for The Defender and part of the rotation of hosts for CHD.TV’s “Good Morning CHD.”
This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.






